Market Scenario
Market Research Future (MRFR) postulates that the global DNA sequencing market is
predicted to demonstrate a CAGR of 17.64% during the forecast period (2018-2023).
Augmenting requirement for animal breeders is estimated to favor the market growth. DNA
sequencing is referred to as a technology where several DNA strands are sequenced through
massive parallelization. It involves both Sanger’s and non-Sanger’s method of sequencing.
The arrangement of the four nucleotide bases such as Cytosine, Guanine, Thymine, and
Adenine can be identified with the help of several sequencing techniques available in the
market. DNA sequencing comprises information associated with the IQ level of the human
beings and genetically determined illness.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5774
Market Potential and Pitfalls
The accelerating adoption of precision medicine along with the augmenting use of
applications such as forensic biology, biotechnology, molecular biology, and virology are
considered to foster the DNA sequencing market throughout the assessment period. With
the increasing investment in research and development activities, the market is anticipated
to gain prominence across the globe. The enzymic method for DNA sequencing has been
extensively used for genomic research. As exact results were obtained during the process,
the demand for DNA sequencing has increased to a large extent. The demand has further
triggered the development of the second-generation sequencing method. Additional factors
gearing up the market growth are the rising requirement for animal breeders and plant
production, rising R&D activities, technological advancements, growth in the liquid biopsy
applications, and increasing incidences of cancer. Moreover, increased use of genome
mapping programs is predicted to boost the market growth. The increasing demand for
inexpensive, accurate, and fast DNA sequencing data has resulted in the advent of a new
generation of sequencing technologies. Continuous changes in technologies coupled with the
creation of new opportunities are some of the other factors likely to attract market players
to the industry, thereby resulting in the market to expand.
On the contrary, lack of reimbursement policies in several nations is predicted to act as a
top barrier hindering the market growth throughout the appraisal period. Moreover,
concerns associated with standardization, accuracy, and legal and ethical limitations of DNA
sequencing are estimated to vitiate the market growth globally.
Competitive Dashboard
The prominent players operating the global DNA sequencing market are Myriad Genetics,
Eppendorf, Hamilton Thorne Biosciences, General Electric Company, Life Technologies,
Roche Holdings AG, Siemens Healthineers GmbH, Agilent Technologies Inc., Perkin Elmer,
Beckman Coulter, Genia Corporation, Bayer Corporation, Siemens AG, Koninklijke Philips
N.V., Tecan, Illumina, Deep Genomics Inc., Illumina, Oxford Nanopore Technologies, Pacific
Biosciences, Johnson & Johnson, Thermo Scientific, and others.
Reports Enquiry @ https://www.marketresearchfuture.com/enquiry/5774
Global DNA Sequencing Market: Segmental Analysis
The global DNA sequencing market has been segmented on the basis of product, type,
application, technology, and end-users.
By mode of type, the global DNA sequencing market has been segmented into workflow
products and instruments and consumables services.
By mode of product, the global DNA sequencing market has been segmented into
sequencing instruments and consumables and sequencing services. Among these, the
sequencing services segment is likely to witness the major share owing to its high demand
globally. Due to the long-time duration taken to complete the sequencing and high-cost of